208 related articles for article (PubMed ID: 9543168)
1. Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas.
Renner U; Arzberger T; Pagotto U; Leimgruber S; Uhl E; Müller A; Lange M; Weindl A; Stalla GK
J Clin Endocrinol Metab; 1998 Apr; 83(4):1368-75. PubMed ID: 9543168
[TBL] [Abstract][Full Text] [Related]
2. Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas.
Su Z; Wang C; Wu J; Jiang X; Chen Y; Chen Y; Zheng W; Zhuge Q; Wu Z; Zeng Y
Neurol Sci; 2012 Apr; 33(2):275-9. PubMed ID: 21748460
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptor gene expression in human adenohypophysial adenomas.
Stefaneanu L; Kovacs K; Horvath E; Buchfelder M; Fahlbusch R; Lancranjan L
Endocrine; 2001 Apr; 14(3):329-36. PubMed ID: 11444429
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.
Caccavelli L; Feron F; Morange I; Rouer E; Benarous R; Dewailly D; Jaquet P; Kordon C; Enjalbert A
Neuroendocrinology; 1994 Sep; 60(3):314-22. PubMed ID: 7969790
[TBL] [Abstract][Full Text] [Related]
5. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
Alexander JM; Swearingen B; Tindall GT; Klibanski A
J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
[TBL] [Abstract][Full Text] [Related]
6. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
7. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
8. Prolactin receptor messenger ribonucleic acid in normal and neoplastic human pituitary tissues.
Jin L; Qian X; Kulig E; Scheithauer BW; Calle-Rodrigue R; Abboud C; Davis DH; Kovacs K; Lloyd RV
J Clin Endocrinol Metab; 1997 Mar; 82(3):963-8. PubMed ID: 9062514
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of nerve growth factor on expression of dopamine 2 receptor subtypes in GH3 rat pituitary tumor cells.
Su Z; Jiang X; Wang C; Liu J; Chen Y; Li Q; Wu J; Zheng W; Zhuge Q; Jin K; Wu Z
Endocrine; 2012 Dec; 42(3):670-5. PubMed ID: 22684586
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
Li Q; Su Z; Liu J; Cai L; Lu J; Lin S; Xiong Z; Li W; Zheng W; Wu J; Zhuge Q; Wu Z
Mol Cell Endocrinol; 2014 Jan; 382(1):377-384. PubMed ID: 24184771
[TBL] [Abstract][Full Text] [Related]
11. Urocortin expression in human pituitary gland and pituitary adenoma.
Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
13. Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells.
Bondioni S; Angioni AR; Corbetta S; Locatelli M; Ferrero S; Ferrante E; Mantovani G; Olgiati L; Beck-Peccoz P; Spada A; Lania AG
Exp Biol Med (Maywood); 2008 Apr; 233(4):439-46. PubMed ID: 18367633
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-producing pituitary tumor: resistance to dopamine agonist therapy. Case report.
Kovacs K; Stefaneanu L; Horvath E; Buchfelder M; Fahlbusch R; Becker W
J Neurosurg; 1995 May; 82(5):886-90. PubMed ID: 7714616
[TBL] [Abstract][Full Text] [Related]
15. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
Oomizu S; Boyadjieva N; Sarkar DK
Alcohol Clin Exp Res; 2003 Jun; 27(6):975-80. PubMed ID: 12824819
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas.
Saveanu A; Gunz G; Guillen S; Dufour H; Culler MD; Jaquet P
Neuroendocrinology; 2006; 83(3-4):258-63. PubMed ID: 17047391
[TBL] [Abstract][Full Text] [Related]
17. Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.
Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Figarella-Branger D; Cortet-Rudelli C; Grisoli F; Jaquet P; Enjalbert A
J Clin Endocrinol Metab; 1996 Sep; 81(9):3390-6. PubMed ID: 8784102
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries.
Sanno N; Jin L; Qian X; Osamura RY; Scheithauer BW; Kovacs K; Lloyd RV
J Clin Endocrinol Metab; 1997 Jun; 82(6):1974-82. PubMed ID: 9177416
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
20. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level.
Pagotto U; Marsicano G; Fezza F; Theodoropoulou M; Grübler Y; Stalla J; Arzberger T; Milone A; Losa M; Di Marzo V; Lutz B; Stalla GK
J Clin Endocrinol Metab; 2001 Jun; 86(6):2687-96. PubMed ID: 11397872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]